Published February 7, 2023
DelveInsight’s “Severe Asthma Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Severe Asthma , historical and forecasted epidemiology as well as the Severe Asthma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Severe Asthma Overview
Asthma is the most common chronic respiratory disease globally. Asthma affects the airways in the lungs, which becomes inflamed and narrowed due to various triggers which makes the flow out of air harder. Asthma can be characterized by wheezing, shortness of breath, cough, a sensation of tightness in the chest, straining of neck and chest muscles, rapid breathing, and changes in heart rate.
Some of the key facts of the Severe Asthma Market Report:
• Severe Asthma market size is anticipated to increase with a significant CAGR during the study period 2019-32.
• In the recent year, among the 7MM countries there were approximately 54,000,000 prevalent cases of Severe Asthma
• The United States holds the highest number of diagnosed asthma cases in adults
• Severe Asthma epidemiology based on Type-specific cases analyzed that there is an equal prevalence of Type-2 inflammation and non-Type-2 inflammation.
• Severe Asthma emerging therapies such as GSK3511294 (depemokimab), PT027, PT010, MRx-4DP0004, CSJ117 (Ecleralimab), AVTX-002, BSI-045B, and other are likely to change the dynamics of severe asthma market.
• There is a surge in the Severe Asthma treatment needs, many key companies are developing therapies for Severe Asthma treatment
• The severe asthma therapies are costly and have an unknown long-term safety profile.
Request a sample for the Severe Asthma Market Report
Key benefits of the Severe Asthma Market report:
1. Severe Asthma market report covers a descriptive overview and comprehensive insight of the Severe Asthma Epidemiology and Severe Asthma market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
2. The Severe Asthma market report provides insights on the current and emerging therapies.
3. Severe Asthma market report provides a global historical and forecasted market covering drug outreach in 7MM.
4. The Severe Asthma market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Severe Asthma market.
Got queries? Click here to know more about the Severe Asthma Market Landscape
Epidemiology Segmentation of Severe Asthma:
• Prevalent Cases of Severe Asthma in the 7MM [2019-2032]
• Age-Specific Cases of Severe Asthma in the 7MM [2019–2032]
• Gender-Specific Cases of Severe Asthma in the 7MM [2019–2032]
• Diagnosed and Treated Cases of Severe Asthma in the 7MM [2019–2032]
Severe Asthma Market
The dynamics of the Severe Asthma market are anticipated to change in the coming years owing to the expected launch of emerging therapies, and others during the forecasted period 2019-2032.
Severe Asthma Market Drivers
• Robust severe asthma pipeline
• Improving severe asthma diagnostic approach.
• Increasing demand for personalized severe asthma therapies.
• Increasing Prevalent cases of Severe Asthma
Severe Asthma Market Barriers
• High cost of severe asthma treatment
• Limitations in severe asthma diagnosis
• Incorrect inhaler techniques
• Poor Adherence to severe asthma treatment
Learn more by requesting for sample @ Severe Asthma Market Landscape
Severe Asthma Pipeline Therapies and Key Companies
• GSK3511294 (depemokimab): GSK
• PT027: AstraZeneca
• PT010: AstraZeneca
• MRx-4DP0004: 4D Pharma
• CSJ117 (Ecleralimab): Novartis
• AVTX-002: Avalo Therapeutics
• BSI-045B: Biosion
Table of Contents
1. Severe Asthma Market Report Introduction
2. Executive Summary for Severe Asthma
3. SWOT analysis of Severe Asthma
4. Severe Asthma Patient Share (%) Overview at a Glance
5. Severe Asthma Market Overview at a Glance
6. Severe Asthma Disease Background and Overview
7. Severe Asthma Epidemiology and Patient Population
8. Country-Specific Patient Population of Severe Asthma
9. Severe Asthma Current Treatment and Medical Practices
10. Severe Asthma Unmet Needs
11. Severe Asthma Emerging Therapies
12. Severe Asthma Market Outlook
13. Country-Wise Severe Asthma Market Analysis (2019–2032)
14. Severe Asthma Market Access and Reimbursement of Therapies
15. Severe Asthma Market drivers
16. Severe Asthma Market barriers
17. Severe Asthma Appendix
18. Severe Asthma Report Methodology
19. DelveInsight Capabilities
21. About DelveInsight
Click here to read more about Severe Asthma Market Outlook 2032
Severe Asthma Pipeline
“Severe Asthma Pipeline Insight, 2023” report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Severe Asthma market. A detailed picture of the Severe Asthma pipeline landscape is provided, which includes the disease overview and Severe Asthma treatment guidelines.
Severe Asthma Epidemiology
DelveInsight’s ‘Severe Asthma Epidemiology Forecast to 2032’ report delivers an in-depth understanding of the disease, historical and forecasted Severe Asthma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Company Name: DelveInsight Business Research LLP
Contact Person: Navdha Goel
Email: [email protected]
State: New York
Country: United States